| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.025 | 0.9 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.9 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.9 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |